Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Medtronic initiates pivotal studies of Resolute Onyx drug-eluting stent in United States

Medtronic plc today announced the start of its Resolute Onyx Clinical Program in the United States, which will evaluate the Resolute Onyx drug-eluting stent (DES) in patients who have coronary artery disease.  Included in the first phase of the study are patients with small vessels that would require a 2.0 mm stent, which until now, often were untreatable with a DES. Core sizes of the stent will be studied separately.

Thumbnail

Structured Reporting: Harnessing Data in the Cath Lab

The cath lab is itself high-tech but some reports generated by its physicians still rely on old-fashioned dictation and transcription. Structured reporting offers a way into the present.

Thumbnail

Cath Lab Inventory Management: Improving the Bottom Line

Cardinal Health

Hospitals and health systems across the U.S. are answering the mandate of the Affordable Care Act to cut unnecessary costs. Florida Hospital Cardiovascular Institute in Orlando, a member of the Adventist Health System, is a hyperachiever—having cut more than $5 million thanks to a fully integrated, RFID-based inventory management solution deployed across their 13 interventional labs. If improving inventory management isn’t part of your arsenal for supply chain savings strategy, it’s time to take a closer look. 

Culprit or complete? Primary PCI findings add to ongoing stenting debate

British researchers comparing primary PCI revascularization in patients with STEMI and multivessel disease found better outcomes for patients when all lesions were treated as opposed to targeting just the culprits.

Thumbnail

Bioresorbable scaffolds, drug-eluting stents equal at 9-month follow-up

In a head-to-head comparison, bioresorbable vascular scaffolds were not inferior to the best performing drug-eluting stents, according to research published online March 3. 

Cardinal Health makes $2B bid for Cordis

Cardinal Health is offering to buy the stent pioneering company Cordis for almost $2 billion, Johnson & Johnson announced.

Thumbnail

Younger women, clinicians often dismiss signs of heart attack

Many younger women think they’re too young for a heart attack, and healthcare providers don’t take their initial symptoms seriously enough, researchers concluded after interviewing 30 women hospitalized for acute MI.

Thumbnail

Guideline-based therapy may be underutilized following PCI, CABG

Rates of optimal care following PCI or CABG surgery were uncomfortably low, according to a study published online Feb. 24 in Circulation. The analysis revealed that by five years of follow-up, only around a third of patients in either group were receiving guideline-based therapies.

Displaying 1577 - 1584 of 2704

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.